David Handelsman is inaugural Professor/Director, ANZAC Research Institute (1998-), Australia’s first Professor of Andrology (Univ of Syd, 1996-) and Head of the first Andrology Department (Concord Hospital, 1999-).
After training in medicine (FRACP Endocrinology) and research (NHMRC & Wellcome Research Fellow), he has worked in USA and Germany and has served numerous research and health policy bodies.
He was awarded the RACP’s Susman Prize (1994), the inaugural AMA Men’s Health Award (2003) and Honorary Life Member, Endocrine Society of Australia (2008). In 2011 he was appointed to the World-Anti-Doping Agency (WADA) Health Medicine and Research Committee.
Over 30 years, he has published more than 360 scientific papers (cited over 8000 times, h index 50), served 12 Editorial Boards (current Associate Editor for Male Reproduction, JCEM) and been ad hoc peer reviewer for over 100 scientific journals, supervised or co-supervised 21 PhD students and 11 other graduate students while maintaining continuous peer-reviewed and industry grant funding.
His expertise in male reproductive health, medicine and biology has involved research into basic, clinical, translational and public health domains centred on the physiology, pharmacology and toxicology of androgens.